Global
Zoledronic Acid Market is expected to grow at a significant CAGR in the
upcoming years as the scope, Product Types, and its applications are increasing
across the globe. Zoledronic acid, or zoledronate, is a bisphosphonate drug to
treat diseases pertaining to the bone. This drug is given intravenously. This
zoledronic acid is typically used for treating bone complications like low bone
density. Zoledronic acid is primarily used to avert bone fracture,
hypercalcemia, bone-related indications, and others. Additionally, it is also used
for the treatment of Paget's disease, and Osteoporosis.

Increase
in prevalence of the diseases like Cancer, the trend of the sedentary
lifestyle, increase in obesity cases and smoking lead to bone complications
such as low bone density, bone fractures, osteoporosis. Additionally, the
decrease in strength of the bone in the geriatric population and rise in the
prevalence of osteoporosis in postmenopausal women are anticipated to increase
the demand for zoledronic aid with the growth of the market.
Adversative
properties of zoledronic such uncommon thigh osteonecrosis and bone fracture of
the jaw & others and strict regulations of government related to the
zoledronic acid hamper the growth of the market. Besides, the existence of
substitutes for zoledronic acid such as alendronate, denosumab, ibandronate,
and risedronate restrains the market development. Constant R&D activities
with regards to zoledronic acid and rise in consciousness regarding bone
diseases & complications are expected to drive the market growth.
Zoledronic
Acid Market is segmented, By Product Type into Powder, and Injection.
Zoledronic Acid Market is classified based on Application into Pagets Disease,
Osteoporosis, Bone Complications. Zoledronic Acid Market is segmented By
Geographical Region into Asia Pacific (China, India, ASEAN, Australia & New
Zealand), Japan, Middle East and Africa (GCC countries, S. Africa, Rest Of
MEA), North America (U.S., Canada), Latin America (Brazil, Rest of Latin
America), Western Europe (Germany, Italy, France, England, Spain, Rest of
Western Europe), and Eastern Europe (Poland, Russia, Rest of Eastern Europe).
Zoledronic
Acid Market Key Players include Teva Pharmaceutical Industries Ltd., Emcure
Pharmaceuticals, ScinoPharm Taiwan, LTD., Tecoland Corp., Cipla Ltd.,Mylan
Pharms Inc., Hangzhou Long Shine Bio-Tech, Natco Pharma Ltd., Taj
Pharmaceuticals Ltd., and Lianyungang Runzhong Pharm.
Comments
Post a Comment